TP53 and cancer: The codon 72 arginine-to-proline polymorphism at the p53 locus affects cancer development, as well as response to therapy and survival of cancer patients (Thomas et al, 1999; Marin et al, 2000; Bergamaschi et al, 2003; Bonafe et al, 2003).